Johnson & Johnsons TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across…
Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology…
Eskuad Revolutionizes Data Collection With Intuitive Mobile Form Builder Free Trial Now Available
ATLANTA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Eskuad, a leading innovator in…
AVATAi Revolutionizes 3D Creation with New Generative AI Platform
An accessible generative AI platform unleashing a new wave of digital creativity—launching…
Where Luxury Meets Tranquillity: Discover Amaraanth, South Goa
MARGAO, India, Dec. 2, 2024 /PRNewswire/ -- Walking distance from Fatrade beach,…
Exclusive hospitality packages launched for Olympic Winter Games Milano Cortina 2026
29 November 2024 - Fans around the world can now access exclusive…
TetraMem Inc and SK hynix Announce Research Partnership
FREMONT, Calif., Nov. 16, 2024 /PRNewswire/ -- Today, TetraMem Inc (www.tetramem.com) &…
KFSHRCs New US Patent Opens New Frontiers for Breast Cancer Treatment
RIYADH, Saudi Arabia, Nov. 10, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist…
e& unveils new global brand positioning inviting the world to “Go for More”
Bringing the brand promise to life with world's biggest icons Jason Statham,…